A Phase 3 interventional study of Internal iliac artery ligation and cesarean hysterectomy in Blood Loss, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to female participants aged 25 Years to 40 Years. Per ClinicalTrials.gov, last updated 2020-07-08.
Sponsored by Ain Shams University · Phase 3, Interventional, and Prevention
40 pregnant females at term diagnosed with morbidly adherent placenta and planned for elective cesarean section were recruited and randomized to 2 groups. Group A: Internal iliac ligation followed by cesarean hysterectomy. Group B: cesarean hysterectomy.
147 studies on the registry are indexed under Placenta Accreta; 39 are open to participants now.
This study's enrollment of 40 is below the median of 62 across 63 interventional studies indexed under Placenta Accreta.
Browse Placenta Accreta studies →Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Internal iliac artery ligation · Procedure: cesarean hysterectomy
Procedure: cesarean hysterectomy
Internal iliac artery ligation and cesarean hysterectomy
Also known as: cesarean hysterectomy
cesarean hysterectomy
Amount of blood loss
Time frame: intraoperative
Amount of Blood transfusion needed in mililiters
Time frame: 24 hours
change of hemoglobin
Time frame: 24 hours
change of hematocrit
Time frame: 24 hours
operative time
Time frame: intraoperative
incidence of injury of important structures during operation
incidence of injury of important structures during operation as urinary bladder, ureteric, intestinal or great vessels injury
Time frame: intraoperative
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ain Shams University